Government announces major prostate cancer screening trial to end needless prostate deaths
21 November 2023
Government announces major prostate cancer screening trial to end needless prostate deaths
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
9 October 2023
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
Walk 60 Miles in November for Prostate Cancer
3 October 2023
Walk 60 Miles in November for Prostate Cancer
PCR submits evidence to the Health and Social Care Committee as part of inquiry into men’s health
5 September 2023
PCR submits evidence to the Health and Social Care Committee as part of inquiry into men’s health
PCR partners with CAC for Prostate Cancer Awareness Month
31 August 2023
PCR partners with CAC for Prostate Cancer Awareness Month
Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data
24 August 2023
Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data
Exploring men’s psychological adjustment to prostate cancer
8 August 2023
Exploring men’s psychological adjustment to prostate cancer
Jeanette Ager Braves the Thames Marathon Swim for Prostate Cancer Research
1 August 2023
Jeanette Ager Braves the Thames Marathon Swim for Prostate Cancer Research
Prostate Cancer Research statement on the NCRI
26 June 2023
Prostate Cancer Research statement on the NCRI
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
18 May 2023
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
Load more